Skip to main content

NXGL

Stock
Health Care
Medical Instruments & Supplies

Performance overview

NXGL Price
Price Chart

Forward-looking statistics

Beta
0.50
Risk
75.30%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

nexgel advanced hydrogel solutions in a manufacturer of unique trans-dermal delivery system that was originally developed and fda-approved for the hospital wound care market, and is now being deployed against consumer otc, rx, medical device and cosmetic applications.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees10
Market cap$13.2M

Fundamentals

Enterprise value$21.7M
Revenue$10.2M
Revenue per employee—
Profit margin-30.70%
Debt to equity49.25

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.45
Dividend per share—
Revenue per share$1.48
Avg trading volume (30 day)$107K
Avg trading volume (10 day)$92K
Put-call ratio—

Macro factor sensitivity

Growth—
Credit—
Liquidity—
Inflation—
Commodities—
Interest Rates—

Valuation

Dividend yield0.00%
PEG Ratio66.25
Price to sales1.98
P/E Ratio66.25
Enterprise Value to Revenue2.12
Price to book3.89

Upcoming events

Next earnings dayMay 14, 2024
Next dividend day—
Ex. dividend day—

News

4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More

U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga (June 28, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free